The economic impact of clostridium difficile infection: A systematic review

American Journal of Gastroenterology

Volumn 110, Issue 4, 2015, Pages 511-519

  Nanwa, Natasha ^a,b   Kendzerska, Tetyana ^c,d   Krahn, Murray ^a,b,c,d,e,f   Kwong, Jeffrey C ^a,c,d,f,g   Daneman, Nick ^c,d,e,h   Witteman, William ⁱ   Mittmann, Nicole ^d,h,j,k   Cadarette, Suzanne M ^a,c   Rosella, Laura ^a,c,g   Sander, Beate ^b,c,e,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

^g PUBLIC HEALTH ONTARIO   (Canada)

^h SUNNYBROOK RESEARCH INSTITUTE   (Canada)

ⁱ LAVAL UNIVERSITY   (Canada)

^j Division of Clinical Pharmacology   (Canada)

^k UNIVERSITY OF WESTERN ONTARIO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; CANADA; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CYSTECTOMY; DECISION MAKING; ECONOMIC EVALUATION; GASTROINTESTINAL SURGERY; GERMANY; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION COST; HUMAN; ILEOSTOMY; INFLAMMATORY BOWEL DISEASE; INTENSIVE CARE UNIT; IRELAND; JAPAN; KIDNEY DISEASE; LIVER CIRRHOSIS; META ANALYSIS; PRIORITY JOURNAL; QUALITY CONTROL; RECURRENT DISEASE; REVIEW; SENSITIVITY ANALYSIS; STRATEGIC PLANNING; STUDY DESIGN; SYSTEMATIC REVIEW; UNITED STATES; CLOSTRIDIUM INFECTION; ECONOMICS; HOSPITALIZATION; PEPTOCLOSTRIDIUM DIFFICILE; PSEUDOMEMBRANOUS COLITIS;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HOSPITALIZATION; HUMANS;

EID: 84927783674     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2015.48     Document Type: Review

References (75)

1. Carroll KC, Bartlett JG. Biology of Clostridium diffi cile: implications for epidemiology and diagnosis. Ann Rev Microbiol 2011; 65: 501-21.
2. Bartlett JG. Historical perspectives on studies of Clostridium diffi cile and C. diffi cile infection. Clin Infect Dis 2008; 46: S4-11.
3. Forster AJ, Taljaard M, Oake N. et al the effect of hospital-acquired infection with Clostridium diffi cile on length of stay in hospital. CMAJ 2012; 184: 37-42.
4. Vonberg RP, Reichardt C, Behnke M. et al. Costs of nosocomial Clostridium difficile-associated diarrhoea. J Hosp Infect 2008; 70: 15-20.
5. Al-Eidan FA, McElnay JC, Scott MG. et al. Clostridium difficile-associated diarrhoea in hospitalised patients. J Clin Pharm Ther 2000; 25: 101-9.
6. Yasunaga H, Horiguchi H, Hashimoto H. et al the burden of Clostridium difficile-associated disease following digestive tract surgery in Japan. J Hosp Infect 2012; 82: 175-80.
7. Wilcox MH, Cunniff e JG, Trundle C. et al. Financial burden of hospitalacquired Clostridium diffi cile infection. J Hosp Infect 1996; 34: 23-30.
8. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium diffi cile in patients with infl ammatory bowel disease. Gut 2008; 57: 205-10.
9. Marco-Martinez J, Barba-Martin R, Plaza-Canteli S. et al. [Clostridium diffi cile infections in Spanish Internal Medicine departments during the period 2005-2010: The burden of the disease.]. Enferm Infecc Microbiol Clin 2014; 33: 16-21.
10. Murphy CR, Avery TR, Dubberke ER. et al. Frequent hospital readmissions for Clostridium diffi cile infection and the impact on estimates of hospitalassociated C. diffi cile burden. Infect Control Hosp Epidemiol 2012; 33: 20-28.
11. Freeman J, Bauer MP, Baines SD. et al the changing epidemiology of Clostridium diffi cile infections. Clin Microbiol Rev 2010; 23: 529-49.
12. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173: 1037-42.
13. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium diffi cilerelated mortality rates, United States, 1999-2004. Emerg Infect Dis 2007; 13: 1417-9.
14. Lucado J, Gould C, Elixhauser A. Clostridium diffi cile Infections (CDI) in Hospital Stays, 2009. Statistical Brief #124. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Health Care Policy and Research (US); 2006-2012 Jan
15. Ricciardi R, Rothenberger DA, Madoff RD. et al. Increasing prevalence and severity of Clostridium diffi cile colitis in hospitalized patients in the United States. Arch Surg 2007; 142: 624-31.
16. Kwong JC, Ratnasingham S, Campitelli MA. et al the impact of infection on population health: results of the Ontario burden of infectious diseases study. PLoS One 2012; 7: e44103.
17. Badger VO, Ledeboer NA, Graham MB. et al. Clostridium diffi cile: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen. JPEN J Parenter Enteral Nutr 2012; 36: 645-62.
18. Gupta A, Khanna S. Community-acquired infection: an increasing public health threat. Infect Drug Resist 2014; 7: 63-72
19. Centers for Disease C, Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep 2005; 54: 1201-5.
20. Zilberberg MD, Tillotson GS, McDonald LC. Clostridium diffi cile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010; 16: 604-9.
21. Benson L, Song X, Campos J. et al. Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol 2007; 28: 1233-5.
22. Larg A, Moss JR. Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics 2011; 29: 653-71.
23. Finkelstein E, Corso P. Cost-of-illness analyses for policy making: a cautionary tale of use and misuse. Exp Rev Pharmacoecon Outcomes Res 2003; 3: 367-9.
24. Goldstein G, Reznik R, Lapsley H. et al. Costing acute myocardial infarction in New South Wales, Australia, based on incidence rather than prevalence methods. Community Health Stud 1986; 10: 31-8.
25. Ghantoji SS, Sail K, Lairson DR. et al. Economic healthcare costs of Clostridium diffi cile infection: a systematic review. J Hosp Infect 2010; 74: 309-18.
26. The Organisation for Economic Co-operation and Development. PPPs and exchange rates. 2014 [cited 14 July 2014]; Available from http: //stats.oecd. org/Index.aspx?DataSetCode=CPL#.
27. U.S. Bureau of Labor Statistics. CPI Infl ation Calculator. 2014 [cited 14 July 2014]; Available from http: //www.bls.gov/data/infl ation-calculator.htm
28. Drummond M, Jeff erson T. Guidelines for authors and peer reviewers of economic submissions to the BMJ the BMJ Economic Evaluation Working Party. BMJ 1996; 313: 275-83.
29. Pelone F, Specchia ML, Veneziano MA. et al. Economic impact of childhood obesity on health systems: a systematic review. Obes Rev 2012; 13: 431-40.
30. Luengo-Fernandez R, Gray AM, Rothwell PM. Costs of stroke using patient-level data: a critical review of the literature. Stroke 2009; 40: e18-e23.
31. Bahadori K, Doyle-Waters MM, Marra C. et al. Economic burden of asthma: a systematic review. BMC Pulm Med 2009; 9: 24.
32. Drummond M, Sculpher M, Torrance G. et al. Methods for the Economic Evaluation of Health Care Programmes, 3rd ed. Oxford University Press: New York, 2005.
33. Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc 1982; 60: 429-62.
34. Jackson T, Nghiem HS, Rowell D. et al. Marginal costs of hospital-acquired conditions: information for priority-setting for patient safety programmes and research. J Health Serv Res Policy 2011; 16: 141-6.
35. Miller MA, Hyland M, Ofner-Agostini M. et al. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 2002; 23: 137-40.
36. Butterworth SA, Koppert E, Clarke A. et al. Recent trends in diagnosis and treatment of Clostridium diffi cile in a tertiary care facility. Am J Surg 1998; 175: 403-7.
37. Campbell R, Dean B, Nathanson B. et al. Length of stay and hospital costs among high-risk patients with hospital-origin Clostridium difficile-associated diarrhea. J Med Econ 2013; 16: 440-8.
38. Jiang Y, Viner-Brown S, Baier R. Burden of hospital-onset Clostridium diffi cile infection in patients discharged from Rhode Island hospitals, 2010-2011: application of present on admission indicators. Infect Control Hosp Epidemiol 2013; 34: 700-8.
39. Pant C, Anderson MP, Deshpande A. et al. Health care burden of Clostridium diffi cile infection in hospitalized children with infl ammatory bowel disease. Infl amm Bowel Dis 2013; 19: 1080-5.
40. Quimbo RA, Palli SR, Singer J. et al. Burden of Clostridium diffi cileassociated diarrhea among hospitalized patients at high risk of recurrent infection. J Clin Outcomes Manag 2013; 20: 544-54.
41. Sammons JS, Localio R, Xiao R. et al. Clostridium diffi cile infection is associated with increased risk of death and prolonged hospitalization in children. Clin Infect Dis 2013; 57: 1-8.
42. Tabak YP, Zilberberg MD, Johannes RS. et al. Attributable burden of hospital-onset Clostridium diffi cile infection: a propensity score matching study. Infect Control Hosp Epidemiol 2013; 34: 588-96.
43. Wilson MZ, Hollenbeak CS, Stewart DB. Impact of Clostridium diffi cile colitis following closure of a diverting loop ileostomy: results of a matched cohort study. Colorectal Dis 2013; 15: 974-81.
44. Ali M, Ananthakrishnan AN, Ahmad S. et al. Clostridium diffi cile infection in hospitalized liver transplant patients: a nationwide analysis. Liver Transpl 2012; 18: 972-8.
45. Kim SP, Shah ND, Karnes RJ. et al the implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer. J Urol 2012; 187: 2011-7.
46. Kuntz JL, Johnson ES, Raebel MA. et al. Epidemiology and healthcare costs of incident Clostridium diffi cile infections identifi ed in the outpatient healthcare setting. Infect Control Hosp Epidemiol 2012; 33: 1031-8.
47. Lipp MJ, Nero DC, Callahan MA. Impact of hospital-acquired Clostridium diffi cile. J Gastroenterol Hepatol 2012; 27: 1733-7.
48. McGlone SM, Bailey RR, Zimmer SM. et al the economic burden of Clostridium diffi cile. Clin Microbiol Infect 2012; 18: 282-9.
49. Pant C, Anderson MP, O'Connor JA. et al. Association of Clostridium diffi cile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database. Transpl Infect Dis 2012; 14: 540-7.
50. Pant C, Deshpande A, Anderson MP. et al. Clostridium diffi cile infection is associated with poor outcomes in end-stage renal disease. J Invest Med 2012; 60: 529-32.
51. Peery AF, Dellon ES, Lund J. et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012; 143: 1179-87. e1-3.
52. VerLee KE, Finks JL, Wilkins MJ. et al. Michigan Clostridium diffi cile hospital discharges: frequency, mortality, and charges, 2002-2008. Public Health Rep 2012; 127: 62-71.
53. Arora V, Kachroo S, Ghantoji SS. et al. High Horn's index score predicts poor outcomes in patients with Clostridium diffi cile infection. J Hosp Infect 2011; 79: 23-6.
54. Glance LG, Stone PW, Mukamel DB. et al. Increases in mortality, length of stay, and cost associated with hospital-acquired infections in trauma patients. Arch Surg 2011; 146: 794-801.
55. Lesperance K, Causey MW, Spencer M. et al the morbidity of Clostridium diffi cile infection aft er elective colonic resection-results from a national population database. Am J Surg 2011; 201: 141-8.
56. Nylund CM, Goudie A, Garza JM. et al. Clostridium diffi cile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med 2011; 165: 451-7.
57. Pakyz A, Carroll NV, Harpe SE. et al. Economic impact of Clostridium diffi cile infection in a multihospital cohort of academic health centers. Pharmacotherapy 2011; 31: 546-51.
58. Stewart DB, Hollenbeak CS. Clostridium diffi cile colitis: factors associated with outcome and assessment of mortality at a national level. J Gastrointest Surg 2011; 15: 1548-55.
59. Wang L, Stewart DB. Increasing hospital costs for Clostridium diffi cile colitis: type of hospital matters. Surgery 2011; 150: 727-35.
60. Bajaj JS, Ananthakrishnan AN, Hafeezullah M. et al. Clostridium diffi cile is associated with poor outcomes in patients with cirrhosis: a national and tertiary center perspective. Am J Gastroenterol 2010; 105: 106-13.
61. Fuller RL, McCullough EC, Bao MZ. et al. Estimating the costs of potentially preventable hospital acquired complications. Health Care Financ Rev 2009; 30: 17-32.
62. Reed IJF, Edris BA, Eid S. et al. Clostridium diffi cile: the new epidemic. Int J Inf Dis 2009; 7.
63. Zilberberg MD, Nathanson BH, Sadigov S. et al. Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. Chest 2009; 136: 752-8.
64. Dubberke ER, Reske KA, Olsen MA. et al. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis 2008; 46: 497-504.
65. Nguyen GC, Kaplan GG, Harris ML. et al. A national survey of the prevalence and impact of Clostridium diffi cile infection among hospitalized infl ammatory bowel disease patients. Am J Gastroenterol 2008; 103: 1443-50.
66. Song X, Bartlett JG, Speck K. et al. Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol 2008; 29: 823-8.
67. Lawrence SJ, Puzniak LA, Shadel BN. et al. Clostridium diffi cile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol 2007; 28: 123-30.
68. O'Brien JA, Lahue BJ, Caro JJ. et al the emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007; 28: 1219-27.
69. Zerey M, Paton BL, Lincourt AE. et al the burden of Clostridium diffi cile in surgical patients in the United States. Surg Infect 2007; 8: 557-66.
70. Kyne L, Hamel MB, Polavaram R. et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium diffi cile. Clin Infect Dis 2002; 34: 346-53.
71. McFarland LV, Surawicz CM, Rubin M. et al. Recurrent Clostridium diffi cile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol 1999; 20: 43-50.
72. Kofsky P, Rosen L, Reed J. et al. Clostridium difficile-a common and costly colitis. Dis Colon Rectum 1991; 34: 244-8.
73. Yannelli B, Gurevich I, Schoch PE. et al. Yield of stool cultures, ova and parasite tests, and Clostridium diffi cile determinations in nosocomial diarrheas. Am J Infect Control 1988; 16: 246-9.
74. Balshem H, Helfand M, Schunemann HJ. et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64: 401-6.
75. Liberati A, Altman DG, Tetzlaff J. et al the PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009; 6: e1000100.